Blockade of T-type calcium channels prevents tonic-clonic seizures in a maximal electroshock seizure model

Neuropharmacology. 2016 Feb:101:320-9. doi: 10.1016/j.neuropharm.2015.09.032. Epub 2015 Oct 9.

Abstract

T-type (Cav3) calcium channels play important roles in neuronal excitability, both in normal and pathological activities of the brain. In particular, they contribute to hyper-excitability disorders such as epilepsy. Here we have characterized the anticonvulsant properties of TTA-A2, a selective T-type channel blocker, in mouse. Using the maximal electroshock seizure (MES) as a model of tonic-clonic generalized seizures, we report that mice treated with TTA-A2 (0.3 mg/kg and higher doses) were significantly protected against tonic seizures. Although no major change in Local Field Potential (LFP) pattern was observed during the MES seizure, analysis of the late post-ictal period revealed a significant increase in the delta frequency power in animals treated with TTA-A2. Similar results were obtained for Cav3.1-/- mice, which were less prone to develop tonic seizures in the MES test, but not for Cav3.2-/- mice. Analysis of extracellular signal-regulated kinase 1/2 (ERK) phosphorylation and c-Fos expression revealed a rapid and elevated neuronal activation in the hippocampus following MES clonic seizures, which was unchanged in TTA-A2 treated animals. Overall, our data indicate that TTA-A2 is a potent anticonvulsant and that the Cav3.1 isoform plays a prominent role in mediating TTA-A2 tonic seizure protection.

Keywords: Anticonvulsant; Local Field Potential; Maximal electroshock seizure; T-type voltage-gated calcium channels; Tonic-clonic seizure.

MeSH terms

  • Analysis of Variance
  • Animals
  • Benzeneacetamides / therapeutic use*
  • Brain / drug effects
  • Brain / metabolism
  • Calcium Channel Blockers / therapeutic use*
  • Calcium Channels, T-Type / genetics
  • Calcium Channels, T-Type / metabolism*
  • Convulsants / toxicity
  • Disease Models, Animal
  • Dose-Response Relationship, Drug
  • Electroshock / adverse effects
  • Evoked Potentials / drug effects
  • Evoked Potentials / genetics
  • Extracellular Signal-Regulated MAP Kinases / metabolism
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Pentylenetetrazole / toxicity
  • Pyridines / therapeutic use*
  • Seizures / etiology
  • Seizures / pathology
  • Seizures / prevention & control*

Substances

  • 2-(4-cyclopropylphenyl)-N-(1-(5-((2,2,2-trifluoroethyl)oxo)pyridin-2-yl)ethyl)acetamide
  • Benzeneacetamides
  • Cacna1g protein, mouse
  • Cacna1h protein, mouse
  • Calcium Channel Blockers
  • Calcium Channels, T-Type
  • Convulsants
  • Pyridines
  • Extracellular Signal-Regulated MAP Kinases
  • Pentylenetetrazole